Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain After Mini-abdominoplasty Surgery

Trial Profile

Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain After Mini-abdominoplasty Surgery

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ropivacaine (Primary)
  • Indications Postoperative pain
  • Focus First in man; Pharmacokinetics
  • Sponsors Cali Pharmaceuticals

Most Recent Events

  • 26 Oct 2022 According to a Cali Biosciences media release, data published in a peer-reviewed medical journal, Japan Journal of Medicine.
  • 19 Nov 2021 According Cali Biosciences media release, results of this study presented at the 20th Annual American Society of Regional Anesthesia and Pain Medicine (ASRA) Meeting.
  • 05 Jun 2020 Status changed from not yet recruiting to completed.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top